Ablation treatment after failed electric heart shock
Part of Heart & circulation clinical trials.
This trial tests whether blocking faulty heart signals from the pulmonary veins (with or without additional “substrate” modification) works better when electric cardioversion doesn’t stop persistent atrial fibrillation. It may help people who remain in atrial fibrillation after cardioversion by reducing symptoms and abnormal rhythm over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have persistent atrial fibrillation (AF) lasting at least 7 days, and it keeps causing symptoms despite at least one anti-arrhythmia medicine (including amiodarone).
- You either: (a) are planned for ablation 4–6 weeks after electric cardioversion, or (b) have persistent AF that didn’t respond to electric cardioversion, with AF still seen on an ECG.
- You are between 18 and 80 years old (at the time of electric cardioversion) and your expected lifespan is more than 5 years.
- You are enrolled with health insurance, and you can sign informed consent.
- You must not have key health conditions that increase risk, such as untreated thyroid overactivity, pregnancy, BMI over 35, or severe COPD.
- You must not have certain heart conditions or major medication/health limitations (examples: a heart valve replacement in the mitral position, cannot take blood thinners, recent stroke/TIA within 6 months, very weak heart pumping).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to perform ablation (a type of heart procedure) for people with persistent atrial fibrillation (AF) that hasn't responded well to medication. The goal is to see if a targeted approach to the left atrium's back wall works better than standard ablation.
This trial tests whether adding extra ablation lines to the standard pulmonary vein isolation procedure is more effective for people with persistent atrial fibrillation that hasn't been helped by medications. The goal is to improve symptoms like palpitations, fatigue, and shortness of breath.
This trial tests a newer, possibly safer way to treat persistent atrial fibrillation using pulsed field ablation. It compares standard vein isolation alone to adding extra ablation spots to improve success.
This trial tests a new method to treat persistent atrial fibrillation (a long-lasting irregular heartbeat) to see if it helps patients who haven't been helped by medication. It focuses on cleaning up the back wall of the heart to restore a normal rhythm.
This study tests a new way to treat persistent atrial fibrillation using short bursts of electricity (pulsed fields) to carefully reset the heart's rhythm. It may help people whose irregular heartbeat has not improved with medication.
This study compares two treatments for persistent atrial fibrillation (AF) that lasts more than 7 days but less than 2 years: electrical cardioversion (a shock to reset your heart rhythm) versus catheter ablation (using radio waves to fix the heart's electrical pathways). It aims to find which option works better for patients like you.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.